Bridge to Life, Ltd., a leading global supplier of organ preservation solutions and organ perfusion technologies, and Tevosol, Inc., a clinical stage medical device startup, announced Tuesday their merger to develop and commercialize groundbreaking new products for the organ transplantation community. The arrangement includes Bridge to Life’s significant financial commitment to manufacture, trial, and launch Tevosol’s portable ex-vivo lung perfusion (EVLP) machine and normothermic organ preservation platform.
Read the full article: Bridge to Life and Tevosol Merge //
Source: https://www.prnewswire.com/news-releases/bridge-to-life-and-tevosol-merge-to-commercialize-portable-normothermic-machine-preservation-technology-platform-for-organ-transplantation-301225086.html